Episode economics

The per-case math of personalized surgery, now that the episode is mandatory.

MSKvalue Insights · July 2026 · For surgery-center and MSK service-line leaders

For a decade, patient-specific planning and implants were sold as clinical elegance — and bought rarely, because under fee-for-service the buyer of “fewer revisions” was nobody. The mandate rewires that. When the facility is accountable for the whole episode, the beneficiary of a better-fitting joint is the facility itself.

The three numbers that matter

What dissatisfaction costs. With ~1 in 5 knee patients not fully satisfied and alignment implicated, every avoided revision or prolonged-recovery case inside your 30-day window is spend you keep. Shared-savings math on a well-run episode runs ~$450/case kept by the provider* — and a single in-window complication can erase ten clean episodes.
What personalization costs. Per-case, no capital: planning fees measured in hundreds, not the capital walls of robotics programs. The comparison isn’t “personalized vs. standard implant cost” — it’s “per-case planning fee vs. probability-weighted revision cost you now own.”
What acquisition costs. Ortho patient acquisition runs $150–600 per lead (fully loaded often far more), wasted on the ~80% who won’t convert to surgery. An episode system inverts this: screened, high-intent patients arrive through assessment funnels, and the non-surgical majority becomes reimbursed co-management under ACCESS (live July 2026, code G0677) instead of lost spend.

Fee-for-service asked: “what does this device cost?” The episode asks: “what does this episode cost, and who keeps the difference when it goes well?” Personalization only ever made economic sense in the second question — and the second question is now the law.

Run your own numbers

Take your last 100 episodes: revision + readmission count inside the window, times your average episode overrun, versus 100 × a per-case planning fee. For most centers the arithmetic is not close. If you want the worksheet version with your own inputs, ask for the briefing — it’s the first thing we walk through.

Start the conversation →

Figures marked * are illustrative and program-dependent; not clinical, legal, or financial advice. MSKvalue assembles independent best-of-class products with the American Joint Replacement Registry as the outcomes backbone.